BreatheSuite

BreatheSuite

Virtual Pulmonary Rehab program for COPD patients. Learn more

Launch date
Employees
Market cap
-
Enterprise valuation
$4—5m (Dealroom.co estimates Jan 2021.)
St. John's Newfoundland and Labrador (HQ)
  • Edit
DateInvestorsAmountRound
-

N/A

-

N/A

-

$550k

Seed
N/A

N/A

Early VC
*

CAD1.2m

Seed
*

N/A

Grant
Total Funding$1.4m

Recent News about BreatheSuite

Edit
More about BreatheSuiteinfo icon
Edit

BreatheSuite is a healthcare technology company focused on improving the lives of individuals with chronic lung diseases such as COPD, asthma, interstitial lung disease, pulmonary fibrosis, bronchiectasis, and post-COVID lung disease. Operating primarily in the United States, BreatheSuite offers a virtual pulmonary rehabilitation (vPR) program that provides patients with the education and support they need to enhance their physical abilities and overall quality of life. The company serves Medicare patients, many of whom can access the program at no cost. BreatheSuite's business model revolves around partnering with healthcare providers and health plans to deliver its services. Revenue is generated through these partnerships and reimbursements from Medicare and other insurance providers. The company leverages technology to create a strong human connection, ensuring that patients receive personalized care and support. BreatheSuite's mission is to make breathing easier and improve the health outcomes of those suffering from respiratory diseases.

Keywords: virtual pulmonary rehab, chronic lung diseases, COPD, asthma, Medicare, healthcare technology, patient education, respiratory support, health plans, personalized care, improved quality of life.

Tech stack

Group
Tech stackLearn more about the technologies and tools that this company uses.